PUBLIC COMPANY
saveXiromed LLC
updated 2mo ago
community read0 votes
pipeline
5
marketed
5
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(5)
pipeline depth5 products
5Marketed
Marketed
(desogestrel + ethinylestradiol) + ethinylestradiol
Female Contraception
Marketed(ethinylestradiol + ferrous fumarate + norethindrone acetate)
Female Contraception
Marketed(levonorgestrel + ethinylestradiol) + ethinylestradiol
Female Contraception
MarketedAltavera
Female Contraception
Marketedmedroxyprogesterone
Female Contraception
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1Open Label Study to Assess the Effect of Patient Use and Robustness of Tiotropium 18ug Inhalation Powder, Hard Capsule,Zephir Inhaler Device
- phase3Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD)
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that